# Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?

> **NCT00441597** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Ischemia Reperfusion Injury
- Cardiovascular Disease

## Interventions

- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00441597
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-02
- **Final completion:** 2009-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441597, "Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00441597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*